IP Library Assignment 057625/0874
Patent Assignment
Reel/Frame 057625/0874

Assignment of Assignor's Interest

Recorded: 2021-09-28 Pages: 9
Assignors
KELLY, BRENDAN
Executed: 2020-10-28
PALMER, JIM
Executed: 2020-10-23
UPASANI, RAVI
Executed: 2020-10-23
PAINTTER, EDWARD
Executed: 2020-10-15
VEMPATI, SRIDHAR
Executed: 2020-10-22
BUTLER, THOMAS
Executed: 2020-10-21
WELSCH, MATTHEW
Executed: 2021-02-03
Assignee
NURIX THERAPEUTICS, INC.
1700 OWENS STREET SUITE 205, SUITE 205, SAN FRANCISCO, CALIFORNIA, 94158
Covered Property (1)
Inhibitors of Menin-Mll Interaction
Application: 17/472,583 →
Publication: US 2022/0024936
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the the Receiving Party Data Previously Recorded at Reel: 057625 Frame: 0874. Assignor(S) Hereby Confirms the Assignment. Oct 10, 2021
From: BRENDAN, KELLY; PALMER, JIM; UPASANI, RAVI; EDWARD, PAINTER
To: BIOMEA FUSION, LLC
Reel/Frame 057759/0619 →
Change of Name Dec 1, 2022
From: BIOMEA FUSION, LLC
To: BIOMEA FUSION, INC.
Reel/Frame 061945/0958 →